Kenneth A. Getz

Articles

Tracking Trial Cost Drivers: The Impact of Comparator Drugs and Co-Therapies

New research from the Tufts Center for the Study of Drug Development identifies a significant contributor to the rising cost of clinical trials-the first step in meeting a growing strategic imperative to help senior management and the regulatory community craft new approaches to make trials more efficient in delivering results to clinicians and patients.